In cancer care, accurate tools for predicting whether a tumor will spread (metastasize) can help patients receive the most appropriate treatments. But existing prediction methods don't always work ...

Balancing Rigor and Urgency: The Development of Trastuzumab Deruxtecan in Rare and Ultra-Rare Sarcomas Cancer genetic counseling and testing have become integral to medicine given expanding knowledge ...

January 30, 2012 — Long-term results from a brain tumor trial show that a chromosomal abnormality — 1p19q codeletion — plays a crucial role in the outcome of patients with oligodendrogliomas. The ...

A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic cancer respond to immunotherapies. The findings, which were recently ...

Pancreatic cancer cells are known for being hard to treat, partly because they change the environment around them to block drugs and immune cells. Scientists discovered that these tumors use a ...

Colorectal cancer is often spoken of as a single disease, but it actually refers to two related cancers: colon cancer and rectal cancer. The latter was recently revealed as the reason we lost the ...

Researchers obtained second-harmonic-generation (SHG) images of more than 300 tumor samples. Their analysis found significant racial differences in a prognostic marker known as the forward-to-backward ...